Screener
Tarsus Pharmaceuticals, Inc. TARS Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s intangibles (net)?
- Tarsus Pharmaceuticals, Inc. (TARS) reported intangibles (net) of $6.89M in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s intangibles (net) changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s intangibles (net) decreased by 12.2% year-over-year, from $7.85M to $6.89M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s intangibles (net)?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s intangibles (net) has grown at a 47.8% compound annual growth rate (CAGR), from $1.05M to $7.37M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude